• by Steve McClellan  @mp_mcclellan, May 5, 2016

Omnicom Health Group has agreed to acquire BioPharm Communications, a specialist in multichannel marketing programs to physicians and healthcare practitioners for pharmaceutical and biotechnology clients. 

The acquisition is designed to bolster Omnicom’s data-driven marketing capabilities in the healthcare sector.

The move is the latest in a series of recent steps the company has taken to expand its healthcare operation, which was reorganized in February when Ed Wise was named CEO, Omnicom Health Group.

In April, the holding company said it was extending its TBWA\WorldHealth, brand which is absorbing two established Omnicom healthcare agencies—LLNS and Corbett. Also last month, it reorganized its CDM healthcare agency brand, consolidating its eight offices around the world under the leadership of newly named CEO Kyle Barich.

Established in 2005 in New Hope, PA, BioPharm counts 17 of the 25 largest pharmaceutical companies in the world as clients. The firm creates customized campaigns that enable healthcare clients to effectively target their desired audiences, and to engage them with content and relevant clinical information.

“BioPharm’s technology, database and insights focused on customer relationship management and audience-responsive content will help Omnicom Health Group expand its leadership position in data-driven healthcare marketing,” said Wise.

BioPharm co-founders Jeff Persinger and Daniel Egeland will continue in their leadership roles as President/CEO, and EVP Chief Sales and Marketing Officer, respectively.  

In addition, other key executives will maintain their current operating roles including Norm Phillips, Chief Strategy Officer; Steve Carickhoff, Chief Operating Officer; and Lars Nordmann, Head of Analytics.